Variant report

Variant	esv3406771
Chromosome Location	chr4:56501220-56503968
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:56501495-56501827	K562	blood:	n/a	n/a
2	ARID3A	chr4:56503388-56504015	K562	blood:	n/a	n/a
3	ATF1	chr4:56501416-56501837	K562	blood:	n/a	n/a
4	BACH1	chr4:56502806-56503160	H1-hESC	embryonic stem cell:	n/a	n/a
5	BACH1	chr4:56503675-56503978	K562	blood:	n/a	n/a
6	BACH1	chr4:56503593-56503801	H1-hESC	embryonic stem cell:	n/a	n/a
7	BACH1	chr4:56502324-56502563	H1-hESC	embryonic stem cell:	n/a	n/a
8	BHLHE40	chr4:56501226-56501818	K562	blood:	n/a	n/a
9	BHLHE40	chr4:56502266-56502629	K562	blood:	n/a	n/a
10	CCNT2	chr4:56501265-56503172	K562	blood:	n/a	chr4:56501740-56501760
11	CHD1	chr4:56502755-56502917	H1-hESC	embryonic stem cell:	n/a	n/a
12	CHD2	chr4:56502112-56503096	K562	blood:	n/a	n/a
13	CHD2	chr4:56502183-56502449	H1-hESC	embryonic stem cell:	n/a	n/a
14	CTBP2	chr4:56501652-56502510	H1-hESC	embryonic stem cell:	n/a	n/a
15	CTCF	chr4:56502322-56502524	A549	lung:	n/a	chr4:56502419-56502432
16	CTCF	chr4:56502141-56502688	K562	blood:	n/a	chr4:56502419-56502432
17	CTCF	chr4:56502321-56502509	Fibrobl	skin:	n/a	chr4:56502419-56502432
18	CTCF	chr4:56502300-56502450	GM12873	blood:	n/a	chr4:56502419-56502432
19	CTCF	chr4:56502270-56502535	HepG2	liver:	n/a	chr4:56502419-56502432
20	CTCF	chr4:56502400-56502550	GM12874	blood:	n/a	chr4:56502419-56502432
21	CTCF	chr4:56502320-56502470	WERI-Rb-1	eye:	n/a	chr4:56502419-56502432
22	CTCF	chr4:56502348-56502502	HepG2	liver:	n/a	chr4:56502419-56502432
23	CTCF	chr4:56502291-56502552	MCF-7	breast:	n/a	chr4:56502419-56502432
24	CTCF	chr4:56502369-56502500	Spleen_OC	spleen:	n/a	chr4:56502419-56502432
25	CTCF	chr4:56502400-56502550	GM12869	blood:	n/a	chr4:56502419-56502432
26	CTCF	chr4:56502245-56502602	GM12878	blood:	n/a	chr4:56502419-56502432
27	CTCF	chr4:56502380-56502530	GM06990	blood:	n/a	chr4:56502419-56502432
28	CTCF	chr4:56502320-56502470	RPTEC	kidney:	n/a	chr4:56502419-56502432
29	CTCF	chr4:56502364-56502488	Pancreas_OC	pancreas:	n/a	chr4:56502419-56502432
30	CTCF	chr4:56502380-56502530	HBMEC	blood vessel:	n/a	chr4:56502419-56502432
31	CTCF	chr4:56502400-56502550	GM12875	blood:	n/a	chr4:56502419-56502432
32	CTCF	chr4:56502340-56502490	GM12866	blood:	n/a	chr4:56502419-56502432
33	CTCF	chr4:56502314-56502529	GM19240	blood:	n/a	chr4:56502419-56502432
34	CTCF	chr4:56502320-56502470	K562	blood:	n/a	chr4:56502419-56502432
35	CTCF	chr4:56502300-56502450	SK-N-SH_RA	brain:	n/a	chr4:56502419-56502432
36	CTCF	chr4:56502356-56502488	GM13976	blood:	n/a	chr4:56502419-56502432
37	CTCF	chr4:56502360-56502510	HEEpiC	esophagus:	n/a	chr4:56502419-56502432
38	CTCF	chr4:56502320-56502470	HepG2	liver:	n/a	chr4:56502419-56502432
39	CTCF	chr4:56502300-56502450	GM12878	blood:	n/a	chr4:56502419-56502432
40	CTCF	chr4:56502320-56502470	GM12866	blood:	n/a	chr4:56502419-56502432
41	CTCF	chr4:56502280-56502430	HCT-116	colon:	n/a	n/a
42	CTCF	chr4:56502240-56502570	MCF-7	breast:	n/a	chr4:56502419-56502432
43	CTCF	chr4:56502380-56502530	GM12874	blood:	n/a	chr4:56502419-56502432
44	CTCF	chr4:56502340-56502490	NHEK	skin:	n/a	chr4:56502419-56502432
45	CTCF	chr4:56502380-56502530	HRE	kidney:	n/a	chr4:56502419-56502432
46	CTCF	chr4:56502314-56502520	GM12891	blood:	n/a	chr4:56502419-56502432
47	CTCF	chr4:56502357-56502493	ProgFib	skin:	n/a	chr4:56502419-56502432
48	CTCF	chr4:56502360-56502510	GM12869	blood:	n/a	chr4:56502419-56502432
49	CTCF	chr4:56502380-56502530	GM12875	blood:	n/a	chr4:56502419-56502432
50	CTCF	chr4:56502363-56502517	Medullo	brain:	n/a	chr4:56502419-56502432

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:56502534-56502584	U87	brain:	n/a
2	chr4:56502864-56502914	HEK293	kidney:	embryo
3	chr4:56502534-56502584	U87	brain:	n/a
4	chr4:56502864-56502914	HEK293	kidney:	embryo
5	chr4:56501718-56501768	AG04449	skin:	fetal
6	chr4:56501978-56502028	HAEpiC	amniotic membrane:	n/a
7	chr4:56501718-56501768	Hela-S3	cervix:	n/a
8	chr4:56501727-56501777	H1-hESC	embryonic stem cell:	embryo
9	chr4:56502392-56502442	SK-N-SH	brain:	n/a
10	chr4:56501441-56501491	HIPEpiC	eye:	n/a
11	chr4:56502116-56502166	HRE	kidney:	n/a
12	chr4:56501978-56502028	SK-N-SH	brain:	n/a
13	chr4:56502116-56502166	Jurkat	blood:	n/a
14	chr4:56502898-56502948	NB4	blood:	n/a
15	chr4:56502529-56502579	CMK	blood:	n/a
16	chr4:56501978-56502028	HRCEpiC	kidney:	n/a
17	chr4:56502898-56502948	HNPCEpiC	eye:	n/a
18	chr4:56502392-56502442	GM19239	blood:	n/a
19	chr4:56502664-56502714	AG04450	lung:	fetal
20	chr4:56501978-56502028	CMK	blood:	n/a
21	chr4:56502469-56502519	SK-N-MC	brain:	n/a
22	chr4:56501978-56502028	SK-N-SH_RA	brain:	n/a
23	chr4:56501978-56502028	T-47D	breast:	n/a
24	chr4:56503521-56503571	AG09319	gingival:	n/a
25	chr4:56502544-56502594	GM12892	blood:	n/a
26	chr4:56501727-56501777	GM19239	blood:	n/a
27	chr4:56502864-56502914	PANC-1	pancreas:	n/a
28	chr4:56502664-56502714	NHDF-neo	bronchial:	n/a
29	chr4:56502392-56502442	GM12878	blood:	n/a
30	chr4:56501727-56501777	PANC-1	pancreas:	n/a
31	chr4:56502544-56502594	MCF-7	breast:	n/a
32	chr4:56502849-56502899	PFSK-1	brain:	n/a
33	chr4:56502529-56502579	GM12892	blood:	n/a
34	chr4:56501727-56501777	HRPEpiC	eye:	n/a
35	chr4:56502664-56502714	HCT-116	colon:	n/a
36	chr4:56502849-56502899	HL-60	blood:	n/a
37	chr4:56502534-56502584	HMEC	breast:	n/a
38	chr4:56502116-56502166	AG10803	skin:	n/a
39	chr4:56502534-56502584	HCM	heart:	n/a
40	chr4:56501441-56501491	NHDF-neo	bronchial:	n/a
41	chr4:56501978-56502028	NT2-D1	testis:	n/a
42	chr4:56502529-56502579	HPAEpiC	pulmonary alveolar:	n/a
43	chr4:56502529-56502579	GM06990	blood:	n/a
44	chr4:56502469-56502519	HNPCEpiC	eye:	n/a
45	chr4:56502534-56502584	GM12878	blood:	n/a
46	chr4:56502898-56502948	NHBE	bronchial:	n/a
47	chr4:56502598-56502648	K562	blood:	n/a
48	chr4:56501718-56501768	HL-60	blood:	n/a
49	chr4:56502392-56502442	AoSMC	blood vessel:	n/a
50	chr4:56502898-56502948	AG09319	gingival:	n/a

No.	Distal block	Cell Line	Cell type
1	chr4:56500129..56502345-chr4:56579313..56582236,2	K562	blood:
2	chr4:56410839..56413778-chr4:56501227..56505067,4	K562	blood:
3	chr4:56411599..56413538-chr4:56502547..56504625,2	MCF-7	breast:
4	chr4:56408119..56414507-chr4:56501105..56505595,8	K562	blood:
5	chr4:56211245..56214093-chr4:56502603..56505420,3	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-NMU-1	chr4:56502711-56502865	NONHSAT096475
2	lnc-NMU-2	chr4:56501440-56501555	l_2648_chr4:56499345-56508927_adipose

Variant related genes	Relation type
NMU	TF binding region
NMU	CpG island
ENSG00000134852	chromatin interactions
ENSG00000272969	chromatin interactions
ENSG00000128039	chromatin interactions

Extended variants
information (count: 96 )
Associated
traits (count: 88 )

Variant overlapped rSNPs/rCNVs (count:96 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs563414521	chr4:56501231-56501232	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
2	rs75641166	chr4:56501258-56501259	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs549229752	chr4:56501268-56501269	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs536125660	chr4:56501356-56501357	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs559573219	chr4:56501393-56501394	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs190830834	chr4:56501428-56501429	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs551652586	chr4:56501446-56501447	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
8	rs571401896	chr4:56501447-56501448	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
9	rs182652696	chr4:56501462-56501463	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
10	rs565644603	chr4:56501493-56501494	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
11	rs1488937	chr4:56501534-56501535	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region lncRNA	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs569834569	chr4:56501603-56501604	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs535532274	chr4:56501626-56501627	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs555573972	chr4:56501650-56501651	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs375050197	chr4:56501690-56501691	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs550832339	chr4:56501727-56501728	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs535052952	chr4:56501749-56501750	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs73236169	chr4:56501770-56501771	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs113607475	chr4:56501775-56501776	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs539523412	chr4:56501790-56501791	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs543428833	chr4:56501805-56501806	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs116523157	chr4:56501841-56501842	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs144511694	chr4:56501859-56501860	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs187207356	chr4:56501946-56501947	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs62308714	chr4:56501961-56501962	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs370189571	chr4:56501962-56501963	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs34661343	chr4:56501973-56501974	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs551243443	chr4:56502056-56502057	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs35772728	chr4:56502094-56502095	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs530687007	chr4:56502102-56502103	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs550176585	chr4:56502105-56502106	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs569697580	chr4:56502115-56502116	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs371017955	chr4:56502158-56502159	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs3792703	chr4:56502178-56502179	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs549062592	chr4:56502188-56502189	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs148426242	chr4:56502211-56502212	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs3792704	chr4:56502220-56502221	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs191242404	chr4:56502225-56502226	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs372332349	chr4:56502261-56502262	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs537810331	chr4:56502273-56502274	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs3838644	chr4:56502293-56502294	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs578218369	chr4:56502299-56502300	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs35771241	chr4:56502304-56502305	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs3828555	chr4:56502307-56502308	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs560231307	chr4:56502331-56502332	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs542600328	chr4:56502352-56502353	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs527754565	chr4:56502363-56502364	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs559497469	chr4:56502376-56502377	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs572813280	chr4:56502428-56502429	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs545209166	chr4:56502485-56502486	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:88)

Disease	PMID	Source
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	22183965	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Lung cancer	18438408	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	21922591	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Parkinson disease	21956041	CNVD
Mental retardation	20522426	CNVD
delayed speech	20522426	CNVD
growth disorder	20522426	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute myeloid leukemia	20729466	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Parkinson disease	18923514	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Breast cancer	16272173	CNVD
Glioblastoma multiforme	19435819	CNVD
Multiple myeloma	16616336	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Ovarian neoplasms	16753589	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Glioblastoma	17504929	CNVD
Glioblastoma	16823502	CNVD
Melanoma	16908931	CNVD
Glioblastoma	20031968	CNVD
Medulloblastoma	19270706	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Olfactory neuroblastoma	18408657	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Rhabdomyosarcoma	16790082	CNVD
Gastrointestinal stromal cancer	17438095	CNVD
Colorectal cancer	16272173	CNVD
Lung cancer	19208797	CNVD
small cell lung cancer	20016488	CNVD
Glioblastoma multiforme	19115005	CNVD
Wilms tumour	21544195	CNVD
Glioblastoma multiforme	21138945	CNVD
Cancer	22183965	CNVD
Autism	22543975	CNVD
Breast cancer	21785460	CNVD

Chromatin state (count:404 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:56499800-56501400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
2	chr4:56500000-56501600	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
3	chr4:56500600-56501600	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
4	chr4:56500600-56501600	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
5	chr4:56500600-56501600	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
6	chr4:56500600-56501800	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
7	chr4:56500800-56501600	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
8	chr4:56500800-56502600	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
9	chr4:56501000-56501400	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
10	chr4:56501000-56501400	Active TSS	Brain Germinal Matrix	brain
11	chr4:56501000-56501400	Bivalent Enhancer	Thymus	Thymus
12	chr4:56501000-56501600	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
13	chr4:56501000-56501600	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
14	chr4:56501000-56501600	Transcr. at gene 5' and 3'	K562	blood
15	chr4:56501000-56503000	Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
16	chr4:56501200-56501400	Flanking Bivalent TSS/Enh	H9 Cell Line	embryonic stem cell
17	chr4:56501200-56501400	Flanking Bivalent TSS/Enh	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
18	chr4:56501200-56501400	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
19	chr4:56501200-56501400	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
20	chr4:56501200-56501400	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
21	chr4:56501200-56501400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
22	chr4:56501200-56501400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
23	chr4:56501200-56501400	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
24	chr4:56501200-56501400	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
25	chr4:56501200-56501400	Bivalent Enhancer	Brain Cingulate Gyrus	brain
26	chr4:56501200-56501400	Bivalent Enhancer	Brain Hippocampus Middle	brain
27	chr4:56501200-56501400	Flanking Active TSS	Esophagus	oesophagus
28	chr4:56501200-56501400	Bivalent/Poised TSS	Fetal Brain Female	brain
29	chr4:56501200-56501600	Flanking Bivalent TSS/Enh	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
30	chr4:56501200-56501600	Bivalent Enhancer	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
31	chr4:56501200-56501600	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
32	chr4:56501200-56501600	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
33	chr4:56501200-56501600	Bivalent Enhancer	Stomach Mucosa	stomach
34	chr4:56501200-56501800	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
35	chr4:56501200-56501800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
36	chr4:56501200-56502000	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
37	chr4:56501200-56502000	Flanking Active TSS	NHEK	skin
38	chr4:56501200-56503200	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
39	chr4:56501200-56503200	Enhancers	Spleen	Spleen
40	chr4:56501400-56501600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
41	chr4:56501400-56501600	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells short term culture	blood
42	chr4:56501400-56501600	Bivalent Enhancer	Brain Angular Gyrus	brain
43	chr4:56501400-56501600	Bivalent Enhancer	Brain Inferior Temporal Lobe	brain
44	chr4:56501400-56501600	Bivalent/Poised TSS	Brain Substantia Nigra	brain
45	chr4:56501400-56501600	Bivalent Enhancer	Duodenum Smooth Muscle	Duodenum
46	chr4:56501400-56501600	Active TSS	Esophagus	oesophagus
47	chr4:56501400-56501600	Bivalent/Poised TSS	Fetal Stomach	stomach
48	chr4:56501400-56501600	Flanking Bivalent TSS/Enh	Rectal Mucosa Donor 31	rectum
49	chr4:56501400-56501600	Enhancers	HMEC	breast
50	chr4:56501400-56501800	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links